Excelsior Medical Co Ltd
TWSE:4104
Intrinsic Value
Excelsior Medical Co. Ltd. engages in the sales and distribution of medical supplies and equipment, medicines and home medical devices. [ Read More ]
The intrinsic value of one Excelsior Medical Co Ltd stock under the Base Case scenario is 91.42 TWD. Compared to the current market price of 90.7 TWD, Excelsior Medical Co Ltd is Undervalued by 1%.
Valuation Backtest
Excelsior Medical Co Ltd
Run backtest to discover the historical profit from buying and selling Excelsior Medical Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Excelsior Medical Co Ltd
| Current Assets | 10.7B |
| Cash & Short-Term Investments | 3.4B |
| Receivables | 5.8B |
| Other Current Assets | 1.5B |
| Non-Current Assets | 7.4B |
| Long-Term Investments | 6B |
| PP&E | 1.1B |
| Intangibles | 45.2m |
| Other Non-Current Assets | 252.6m |
| Current Liabilities | 6.7B |
| Accounts Payable | 974.7m |
| Short-Term Debt | 1.1B |
| Other Current Liabilities | 4.6B |
| Non-Current Liabilities | 2.8B |
| Long-Term Debt | 236.8m |
| Other Non-Current Liabilities | 2.6B |
Earnings Waterfall
Excelsior Medical Co Ltd
|
Revenue
|
8.2B
TWD
|
|
Cost of Revenue
|
-6.6B
TWD
|
|
Gross Profit
|
1.7B
TWD
|
|
Operating Expenses
|
-966.8m
TWD
|
|
Operating Income
|
702.9m
TWD
|
|
Other Expenses
|
43.7m
TWD
|
|
Net Income
|
746.6m
TWD
|
Free Cash Flow Analysis
Excelsior Medical Co Ltd
Profitability Score
Profitability Due Diligence
Excelsior Medical Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Excelsior Medical Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Excelsior Medical Co Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.
Score
Excelsior Medical Co Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Excelsior Medical Co Ltd
According to Wall Street analysts, the average 1-year price target for Excelsior Medical Co Ltd is 77.2 TWD .
Shareholder Return
Price
Excelsior Medical Co Ltd
| Average Annual Return | 14.13% |
| Standard Deviation of Annual Returns | 7.15% |
| Max Drawdown | -16% |
| Market Capitalization | 14.1B TWD |
| Shares Outstanding | 155 616 740 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Excelsior Medical Co. Ltd. engages in the sales and distribution of medical supplies and equipment, medicines and home medical devices. The company is headquartered in Taipei, New Taipei. The company went IPO on 2001-06-08. The Company’s principal products include artificial kidneys, hemodialysis blood tubing sets and epidural needles, dialysis liquid medicines and powder medicines, dialysis machines, human erythropoietin, surgery consumable materials, blood bags, plasma replacement machines and beauty medical equipment, among others. The firm is also involved in the production and sales of self-owned soybean milk machines, as well as household air fresheners under the brand name of Coway. The firm mainly operates its businesses in domestic market and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Excelsior Medical Co Ltd stock under the Base Case scenario is 91.42 TWD.
Compared to the current market price of 90.7 TWD, Excelsior Medical Co Ltd is Undervalued by 1%.
You don't have any saved screeners yet
